Fractalkine Increases Progesterone Production in Human Ovary
Author Information
Author(s): Huang Shuo, Zhao Ping, Yang Liying, Chen Yuan, Yan Jie, Duan Enkui, Qiao Jie
Primary Institution: Peking University Third Hospital
Hypothesis
The study aimed to determine the expression levels of fractalkine and CX3CR1 in the human ovary and to investigate their roles in sexual hormone biosynthesis by human luteinising granulosa cells.
Conclusion
Fractalkine can increase the biosynthesis of progesterone in a dose-dependent manner by enhancing transcript levels of key steroidogenic enzymes.
Supporting Evidence
- Fractalkine and CX3CR1 were expressed in the human ovary and in luteinising granulosa cells.
- Treatment with fractalkine augmented hCG stimulation of progesterone production in a dose-dependent manner.
- Fractalkine had no effect on estradiol biosynthesis.
Takeaway
Fractalkine helps the ovaries make more progesterone, which is important for pregnancy.
Methodology
Fractalkine and CX3CR1 expression levels were measured by immunohistochemistry using ovarian tissue from five individuals, and granulosa cells were cultured and treated with hCG with or without fractalkine.
Limitations
The study did not directly demonstrate the existence of a functional fractalkine receptor on human granulosa cells.
Participant Demographics
Five patients aged 32-49 years who underwent ovary excision due to benign ovarian lesions.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website